Lei Yan

机构：Fujian Medical University, First Affiliated Hospital of Fujian Medical University, Beibu Gulf University

发表论文 40 篇 · 总被引 461 次 · h-index 8

代表论文

• The Calcilytic Drug Calhex-231 Ameliorates Vascular Hyporesponsiveness in Traumatic Hemorrhagic Shock by Inhibiting Oxidative Stress and miR-208a-Mediated Mitochondrial Fission (2020 · Oxidative Medicine and Cellular Longevity · 被引 49)
• MicroRNA-155-5p promotes tumor progression and contributes to paclitaxel resistance via TP53INP1 in human breast cancer (2021 · Pathology - Research and Practice · 被引 44)
• MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer (2019 · Gene · 被引 43)
• <p>Integrative gene expression profiling reveals that dysregulated triple microRNAs confer paclitaxel resistance in non-small cell lung cancer via co-targeting MAPT</p> (2019 · Cancer Management and Research · 被引 18)
• Impact of the Tranexamic Acid on Bleeding Amount of Surgical Patient With Degenerative Spinal Disease: A Randomized Blinded Study (2021 · Frontiers in Surgery · 被引 10)
• <p>Next Generation Sequencing Reveals a Synchronous Trilateral Lung Adenocarcinoma Case with Distinct Driver Alterations of EGFR 19 Deletion or EGFR 20 Insertion or EZR-ROS1 Fusion</p> (2020 · OncoTargets and Therapy · 被引 7)